The triggering of Fas initially appeared as a promising approach to treat cancer but an agonistic anti-Fas antibody triggered fulminant lethal hepatitis upon injection in mice, precluding the use of Fas inducers for a therapeutical purpose in human [3]. Here, FAS is linked to Hepatitis.